Ferritin Above 300 in the Male Masters Athlete: The Paired Ferritin-and-Transferrin-Saturation Workup, the HFE Hereditary Hemochromatosis Referral, and Why the Primary Care Read of "Iron Stores Excellent" Is the Wrong Direction

Every sports nutrition intake protocol I have seen carries a low-ferritin trigger. Almost none carry a high-ferritin trigger. In the female-athlete population the epidemiology defends that asymmetry — iron deficiency is common enough and iron overload rare enough that the workflow can afford to look only in one direction. In the male masters athlete population — the growing 45-to-70-year-old demographic that increasingly shows up in the sports RD's referral base, running marathons on age-group placements, cycling gran-fondos, competing in Olympic-distance triathlons on a training volume that would embarrass athletes half their age — the epidemiology inverts. Iron overload is the pattern the intake needs to catch, not deficiency. And it is being missed at scale because the ferritin reading is being read against the wrong reference in the primary care office that produced the panel.

A 52-year-old male competitive masters cyclist arrives on referral from his primary care for a "diet consult around endurance training and recovery." His annual physical panel from three weeks ago shows a serum ferritin of 587 ng/mL, a serum iron of 178 mcg/dL, a TIBC of 320 mcg/dL, a computed transferrin saturation of 56%, and a hemoglobin of 15.8 g/dL. The primary physician's note reads "iron stores excellent, no repeat needed." He is asymptomatic. He is training 12 to 14 hours per week on the bike, races monthly at the state level in his age group, and has recently switched to a new "endurance multivitamin" that contains 18 mg elemental iron per serving because a training partner told him iron would help with recovery. His father died at 61 of what the family remembers as "some kind of liver problem." He has never been tested for hereditary hemochromatosis.

This case is the workup the sports RD should own, not defer. The primary's read of "iron stores excellent" is the wrong direction. The ferritin is well above the reference upper flag for an asymptomatic adult male, the transferrin saturation is above the 45 percent cutoff that triggers the iron-overload differential in the AASLD 2019 guidance, the endurance-athlete demographic is exactly the population in which occult HFE hereditary hemochromatosis surfaces late in the fifth and sixth decades, and the paternal history is the family-clustering signal an autosomal-recessive inherited condition throws before it is diagnosed formally. The plan does not start with a diet recommendation. It starts with the transferrin-saturation confirmation, the HFE genotyping referral back to the primary physician with the specific workup question named, and a documented supplement audit that pulls the 18 mg elemental iron out of the daily multivitamin.

Why the "Ferritin Excellent" Read Misses Overload

Serum ferritin is a nonspecific storage-iron marker with an established acute-phase-reactant behavior. Reference ranges vary by lab but the male adult reference typically runs 30 to 400 ng/mL with wide interlaboratory variation on the upper bound. Above 300 ng/mL in a male without an inflammatory driver, the differential expands from "adequate stores" to a decision tree that includes chronic inflammation, alcohol-related hepatic pathology, metabolic syndrome, and iron overload — with HFE hereditary hemochromatosis as the specific inherited-condition driver most sports RDs will encounter in the masters demographic. The interpretation the primary physician offered — "excellent" — is a read against a lower boundary that does not apply to the upper end of the range and does not exist in the current iron-overload interpretive literature. The workflow that treats the ferritin metric as a floor-only signal was optimized for anemia identification in general medicine, and it does not translate to a demographic in which occult iron overload has become the more probable pattern.

The transferrin saturation is where the read gets diagnostic. Transferrin saturation (TSAT) is computed as (serum iron divided by TIBC) multiplied by 100, and reports the percentage of the transferrin pool that is loaded with iron. A TSAT above 45 percent in a male, or above 50 percent in a female, is the American Association for the Study of Liver Diseases threshold that triggers workup for iron overload including HFE hereditary hemochromatosis. In the case above the TSAT of 56 percent clears the threshold decisively. The paired reading of ferritin above 300 with TSAT above 45 percent is the specific-and-sensitive combination the workup depends on, and the primary physician's panel had every piece of it — it just was not being read for the pattern because the workflow prompt on the panel result was "screen for anemia."

Chronic inflammation is the alternative differential and needs to be ruled out with a same-draw hs-CRP because inflammation elevates ferritin (acute-phase reactant) but does not typically drive TSAT above 45 percent. In this case the paired-panel expansion is the hs-CRP; if it comes back below 3 mg/L in an asymptomatic athlete, the elevated ferritin is not being driven by inflammation and the iron-overload differential holds cleanly. If it comes back above 3 mg/L, the ferritin read gets modified downward for the acute-phase contribution and the workup pauses until a follow-up panel outside a training block or acute inflammatory event can be drawn to isolate the iron-overload signal from the inflammation signal.

The HFE Hereditary Hemochromatosis Signal

Hereditary hemochromatosis is the most common autosomal-recessive genetic disorder in populations of Northern European ancestry. The C282Y variant of the HFE gene has a homozygous prevalence around 1 in 200 to 1 in 300 in this ancestry group, with compound heterozygosity for C282Y and H63D representing an additional smaller-effect variant pattern that surfaces on the same workup. The condition drives progressive intestinal iron hyperabsorption across the lifespan, gradually loading the liver, pancreas, heart, joints, and endocrine tissues. Untreated homozygous HFE hemochromatosis in males typically progresses to symptomatic organ damage — cirrhosis, iron-overload cardiomyopathy, endocrine failure, or arthropathy of the second and third metacarpophalangeal joints — by the sixth decade of life. In the masters athlete demographic, the exact 50-to-70-year-old population increasingly represented on referral to sports nutrition, this is the pattern the intake should be trained to catch.

The clinical presentation is deceptive. Male athletes with HFE homozygosity often remain asymptomatic through the fourth and fifth decades because the iron-loading trajectory is slow and the body compensates well through much of the trajectory. The first flags surface on routine bloodwork — ferritin drift into the 300s, then the 500s, then the 800s across sequential annual panels — before any symptomatic joint pain, fatigue, hepatomegaly, or elevated liver enzymes appear. The athlete who arrives at the RD with a ferritin above 300 and no symptoms is the athlete whose workup can catch the pattern before it produces liver fibrosis, cardiomyopathy, or diabetes. The workup that catches it earliest is the paired ferritin-plus-TSAT read this post is about.

Family history is the additional signal that raises pretest probability. Any first-degree relative with a diagnosis of hereditary hemochromatosis, cirrhosis of unclear etiology, unexplained liver failure, iron-overload cardiomyopathy, or "some kind of liver problem" the family cannot name specifically should trigger the workup regardless of where the paired panel lands. In the case above, the paternal history of liver failure at 61 is the family-clustering signal I would document in the SOAP even if the ferritin and TSAT were less clear. Hereditary hemochromatosis has a well-documented pattern of underdiagnosis in prior generations because the C282Y HFE variant was not identified until 1996; older family history is more likely to carry undiagnosed hereditary hemochromatosis cases misattributed to alcohol or general liver failure than to represent a truly separate etiology.

The Paired Panel Protocol

The paired workup I order on any male masters athlete presenting with a ferritin above 300 ng/mL, or any female athlete presenting with a ferritin above 200 ng/mL, or any athlete with a family history of hemochromatosis regardless of the ferritin reading, is: serum iron, total iron-binding capacity (TIBC), transferrin saturation (computed from the ratio of serum iron to TIBC), serum ferritin, and hs-CRP for the inflammation modifier. If the paired panel confirms elevated ferritin plus TSAT above 45 percent with a normal hs-CRP, the workup expands to a referral for HFE genotyping (C282Y and H63D variants) through the athlete's primary or through a hepatology consult depending on the referral network the practice runs with. The RD does not order the HFE test directly in most practice patterns, but the RD is the professional who identifies the pattern and communicates the specific referral question to the ordering provider — which is not the same visit as the "diet consult" the referring physician originally opened.

Reference-range read on the paired workup:

• Ferritin: 30 to 400 ng/mL typical male reference, 15 to 200 ng/mL typical female reference. Above 300 in an asymptomatic male, or above 200 in an asymptomatic female without an inflammatory driver, is the trigger for the paired workup, not the "excellent" read.
• Serum iron: 60 to 170 mcg/dL typical adult reference. Interpret against TIBC — the individual number is less informative than the ratio.
• TIBC: 240 to 450 mcg/dL typical adult reference. A depressed TIBC in the setting of elevated ferritin and elevated TSAT is the classic iron-overload lab pattern; the transferrin pool is saturated and downregulated.
• Transferrin saturation: below 45 percent in males and below 50 percent in females is the workup-clearing read. Above these thresholds triggers the iron-overload differential.
• hs-CRP: below 3 mg/L is the read that supports iron overload as the differential over acute-phase-reactant-driven ferritin elevation. Above 3 mg/L, the ferritin read gets modified and the workup pauses for a repeat outside the inflammatory window.

The SOAP Documentation

The assessment line has to name the differential explicitly because the plan involves a referral back to the primary — the same primary who read the panel as excellent — and a supplement discontinuation the athlete may push back on because the multivitamin came from a trusted training partner. My assessment structure on this pattern reads: "Iron-overload workup indicated. Serum ferritin at [value] ng/mL above the 300 ng/mL upper flag for asymptomatic males, transferrin saturation at [value] percent above the 45 percent AASLD threshold for iron-overload workup, hs-CRP at [value] mg/L not indicating acute-phase-reactant masking of the ferritin read. Paternal family history of undifferentiated liver failure at 61 years old raises pretest probability for HFE hereditary hemochromatosis in a Northern European ancestry male. Endurance multivitamin containing 18 mg elemental iron initiated [date], contributing to but not the sole driver of the observed pattern given the family history, the magnitude of the paired-panel findings, and the timeline the supplement was introduced against the panel result date."

The plan documents four elements: discontinue the iron-containing multivitamin effective the visit date; nutritional recommendation of moderated red meat frequency to two servings per week during the pre-workup interval, delayed vitamin C administration by at least two hours away from iron-rich meals, and paired tea or coffee timing with iron-rich meals as an intake-reducing measure through polyphenol chelation; specific referral back to the primary with the documented rationale for HFE C282Y and H63D genotyping plus a hepatology consult if the genotype is positive; and reassessment of the paired ferritin, TSAT, and hs-CRP panel at 10 to 12 weeks with the intake modification in place, with the athlete flagged for repeat monitoring quarterly if the genotype confirms homozygosity or compound heterozygosity.

The referring physician gets a same-day communication that names the pattern in one paragraph, cites the AASLD 2019 guidance on the 45 percent TSAT threshold, and closes the loop that the "diet consult" request opened by redirecting it into the diagnostic workup the panel actually indicated. The communication does not pass judgment on the initial "excellent" read; it documents the pattern the paired panel now reveals and requests the next step in the workup as a partnership rather than a correction. The tone matters because the ongoing referral relationship depends on the primary continuing to send the intake sheet the RD is now demonstrating clinical value on.

The Reassessment and Therapeutic Phlebotomy Loop

If the HFE genotype confirms C282Y homozygosity or C282Y/H63D compound heterozygosity, the athlete transitions to a hepatology-managed therapeutic phlebotomy protocol as the standard of care — typically 500 mL whole-blood removal every 1 to 2 weeks until ferritin drops to the 50 to 100 ng/mL target range, then quarterly maintenance phlebotomy indefinitely. The nutrition role continues throughout the induction and maintenance phases: monitoring dietary iron intake, coordinating iron-food-timing recommendations around ascorbate-containing foods and polyphenol-containing beverages, documenting any recurrence of ferritin drift on the maintenance protocol, and coordinating training-load adjustments around the induction-phase phlebotomy schedule.

The masters athlete population responds well to therapeutic phlebotomy from a training-performance standpoint because the induction-phase blood removals mimic the plasma volume adjustments the athlete already accommodates for altitude and hydration modification. The performance decrement from an induction-phase 500 mL phlebotomy is measurable but transient (48 to 72 hours) and does not compound across the induction sequence in most cases when the phlebotomy cadence is spaced at 10 to 14 days. The training-modification conversation is one the sports RD is well-positioned to have because the athlete trusts the sports-nutrition professional on the exercise-adaptation math in a way they may not trust the hepatology consult on the same question. The RD's role on the multidisciplinary team is to hold the training-cycle interface between the medical protocol and the competitive calendar the athlete is planning around.

If the HFE genotype is negative — meaning ferritin elevated but no C282Y or H63D variant surfaced — the differential expands to secondary causes: alcohol intake pattern review against the AUDIT-C screen, metabolic-syndrome workup including fasting insulin and A1c, and hepatology referral for imaging to rule out non-alcoholic fatty liver disease or other hepatic pathology. The paired panel still holds diagnostic value even when the genetics come back clean; it identifies the pattern that needs a broader medical workup than the sports nutrition visit alone. In this scenario the sports RD hands the broader workup to hepatology but retains the dietary-audit and monitoring role that the initial paired panel opened.

The Case-Pattern Prevalence

The elevated-ferritin pattern in male masters athletes shows up in my referral base at a rate that has surprised me across the last five years of practice. The drivers are a combination of true HFE prevalence in a demographic increasingly represented in endurance sports, iron-fortified nutrition products marketed at older athletes for "recovery" and "energy" reasons without a corresponding update to the standard-of-care advisory that adult men without documented deficiency should not be supplementing iron, and a primary-care read pattern that treats ferritin as a floor-only metric because the general-medicine workflow is optimized for anemia identification. Any sports RD building an intake protocol for the masters age band should carry an explicit ferritin-ceiling trigger alongside the ferritin-floor trigger the endurance-female workflow already uses. The trigger set is asymmetric across sex and age: female athletes 18-45 need the floor; male athletes above 45 need the ceiling; both need family history captured at the intake.

Where Calsanova Fits

The paired ferritin-plus-TSAT read requires the intake to hold three data points — ferritin, TSAT (computed from serum iron and TIBC), and hs-CRP — with the correct interpretation logic layered on top and the reassessment cadence tracked automatically against the athlete's competitive calendar. Calsanova's clinical intake carries the paired-panel entry with automatic TSAT computation on serum iron and TIBC entry, the ferritin-ceiling flag in addition to the more common ferritin-floor flag with sex-and-age-specific thresholds, and the family-history capture at the intake so the pretest-probability signal is documented before the panel is even reviewed. The reassessment loop schedules the 10-to-12-week paired panel automatically and prompts the athlete for the interim supplement-audit confirmation. If your intake is on paper today, the pattern is available on the lab data your athletes already have — it just takes the ceiling-side trigger to be built into the workflow, and the SOAP structure to be documented so the referring physician receives the specific workup question rather than the general "diet consult" bounce.

Ready to move your sports-nutrition intake workflow into a purpose-built clinical system? Try Calsanova free for 30 days — no credit card, HIPAA-ready from day one, and the paired-panel ferritin-plus-TSAT interpretation runs automatically on every lab entry.